TR20 20mg*10vials

Tirzepatide TR20 20mg*10vials

Tirzepatide is a dual GLP-1 and GIP receptor agonist peptide, representing a high-concentration metabolic research compound that activates two gut hormone pathways simultaneously.

The 20mg single-vial specification delivers double the active ingredient content of the standard 10mg. This formulation is ideal for long-term dual-pathway studies, high-dose metabolic experiments, and researchers conducting extended large-animal research. The higher concentration per vial significantly reduces the number of vials needed for prolonged experiments, minimizing handling variables and operational errors from repeated dilution.

Through combined GLP-1 and GIP receptor activation, this compound supports in-depth research into insulin sensitivity, glycemic regulation, appetite-related signaling, and metabolic homeostasis. The dual pathway approach provides a comprehensive scope for studying systemic metabolic regulation across extended study durations.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Every batch undergoes rigorous purity testing, with a complete certificate of analysis provided.

10 vials per pack, designed for long-term preclinical research and high-intensity dual-pathway metabolic projects.